Action Novartis Ag Basel Namen ... (PK) - NVSEF

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

104,146

Prix Achat

100,41

Prix Vente

119,85

Volume échangé

0,00 Fourchette du Jour 0,00

90,24 Plage de 52 semaines 123,55

Cap du marché

220,586B

Clôture Veille

104,146

Ouverture

Dernière Transaction

106.382

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

139 641

Actions en circulation

2 118 043 712

Rendement du Dividende

Ratio Cours sur Bénéfices

18,47

Bénéfice par action (BPA)

5,64

Chiffre d'affairess

51,72B

Bénéfice net

11,94B

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.novartis.com

Siège social

Basel, Che

Fondé

Novartis Ag Basel Namen Akt (PK) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker NVSEF. Le dernier cours de clôture d'Novartis Ag Basel Namen ... (PK) était de US$104,15. Au cours de la dernière année, les actions de Novartis Ag Basel Namen ... (PK) ont été négociées dans une fourchette de prix de US$ 90,24 à US$ 123,55.

Novartis Ag Basel Namen ... (PK) compte actuellement 2 118 043 712 actions en circulation. La capitalisation boursière d'Novartis Ag Basel Namen ... (PK) est de US$220,59 milliard. Novartis Ag Basel Namen ... (PK) a un ratio cours/bénéfice (ratio PE) de 18.47.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	6.846	7.03597122302	97.3	107.77	97.3	82750	104.30115461	CS
4	-6.561	-5.92645451507	110.707	116.6	97.3	195681	108.79776251	CS
12	4.9194	4.9577431858	99.2266	119.85	97.3	139641	107.31878663	CS
26	-8.164	-7.26916570207	112.31	119.85	94.696	94211	106.42223254	CS
52	13.906	15.4100177305	90.24	123.55	90.24	55945	106.12430563	CS
156	13.146	14.4461538462	91	123.55	72.98	55083	95.10326157	CS
260	14.646	16.3642458101	89.5	123.55	72.98	45022	92.37660847	CS

NVSEF - Frequently Asked Questions (FAQ)

What is the current Novartis Ag Basel Namen ... (PK) share price?

The current share price of Novartis Ag Basel Namen ... (PK) is US$ 104,146

How many Novartis Ag Basel Namen ... (PK) shares are in issue?

Novartis Ag Basel Namen ... (PK) has 2 118 043 712 shares in issue

What is the market cap of Novartis Ag Basel Namen ... (PK)?

The market capitalisation of Novartis Ag Basel Namen ... (PK) is USD 220,59B

What is the 1 year trading range for Novartis Ag Basel Namen ... (PK) share price?

Novartis Ag Basel Namen ... (PK) has traded in the range of US$ 90,24 to US$ 123,55 during the past year

What is the PE ratio of Novartis Ag Basel Namen ... (PK)?

The price to earnings ratio of Novartis Ag Basel Namen ... (PK) is 18,47

What is the cash to sales ratio of Novartis Ag Basel Namen ... (PK)?

The cash to sales ratio of Novartis Ag Basel Namen ... (PK) is 4,26

What is the reporting currency for Novartis Ag Basel Namen ... (PK)?

Novartis Ag Basel Namen ... (PK) reports financial results in USD

What is the latest annual turnover for Novartis Ag Basel Namen ... (PK)?

The latest annual turnover of Novartis Ag Basel Namen ... (PK) is USD 51,72B

What is the latest annual profit for Novartis Ag Basel Namen ... (PK)?

The latest annual profit of Novartis Ag Basel Namen ... (PK) is USD 11,94B

What is the registered address of Novartis Ag Basel Namen ... (PK)?

The registered address for Novartis Ag Basel Namen ... (PK) is PO BOX, BASEL, 4002

What is the Novartis Ag Basel Namen ... (PK) website address?

The website address for Novartis Ag Basel Namen ... (PK) is www.novartis.com

Which industry sector does Novartis Ag Basel Namen ... (PK) operate in?

Novartis Ag Basel Namen ... (PK) operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
STTOSITO Mobile Ltd (CE)	US$ 0,16 (79 900,00%)	278
ELIQQElectriq Power Holdings Inc (CE)	US$ 0,02 (19 900,00%)	106
YVRLFLiquid Media Group Ltd (CE)	US$ 0,0001 (9 900,00%)	629
CENBFCEN Biotech Inc (CE)	US$ 0,0001 (9 900,00%)	2,52k
NSPTNewron Sport (PK)	US$ 0,0001 (9 900,00%)	20k
AILEQiLearningEngines Inc (CE)	US$ 0,000001 (-100,00%)	111,69k
TRCNFTransnational Cannabis Ltd (CE)	US$ 0,000001 (-99,90%)	1,5k
HGYNHong Yuan Holding Group (PK)	US$ 0,0001 (-99,60%)	5,36k
MCRTMicroart Inc (CE)	US$ 0,000001 (-99,50%)	590
ZAZAZaZa Energy Corporation (CE)	US$ 0,000001 (-99,00%)	1,62k
TMSHTransGlobal Assets Inc (PK)	US$ 0,0003 (-25,00%)	363,17M
KGKGKona Gold Beverage Inc (PK)	US$ 0,0001 (0,00%)	329,68M
DPLSDarkPulse Inc (PK)	US$ 0,00035 (-30,00%)	277,51M
VGTLVGTel Inc (PK)	US$ 0,002 (100,00%)	249,77M
EMEDElectroMedical Technologies Inc (PK)	US$ 0,0002 (-33,33%)	248,47M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Novartis Ag Basel Namen Akt (PK) (NVSEF)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Novartis Ag Basel Namen Akt (PK)

NVSEF Dernières nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

NVSEF - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Novartis Ag Basel Namen Akt (PK) (NVSEF) Cours

Novartis Ag Basel Namen Akt (PK) (NVSEF)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Novartis Ag Basel Namen Akt (PK)

NVSEF Dernières nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

NVSEF - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités